Perritt Capital Management Inc Pro Phase Labs, Inc. Call Options Transaction History
Perritt Capital Management Inc
- $180 Million
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding PRPH
# of Institutions
35Shares Held
2.98MCall Options Held
12.3KPut Options Held
0-
Sykon Capital LLC Harrison, NY645KShares$225,6780.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA408KShares$142,8930.0% of portfolio
-
Geode Capital Management, LLC Boston, MA259KShares$90,6720.0% of portfolio
-
High Tower Advisors, LLC Chicago, IL229KShares$80,3080.0% of portfolio
-
Quinn Opportunity Partners LLC Charlottesville, VA218KShares$76,3440.01% of portfolio
About ProPhase Labs, Inc.
- Ticker PRPH
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 16,024,400
- Market Cap $5.61M
- Description
- ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements in the United States. The company operates in two segments, Diagnostic Services and Consumer Products. It offers a range of OTC dietary supplements, including Lege...